GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...

Hair loss was not a reported side effect of Mounjaro, but it was reported with other GLP-1 agonists. Mounjaro can cause side effects, such as nausea, vomiting, and diarrhea. But, hair loss was not ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

GLP-1 receptor agonist use before pregnancy was tied to ... Now, we know what the potential effect size of these drugs might be. Now, let’s document in a prospective study that improved ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.